Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Meijer

Showing results (351-360 of 378) with videos related to

Pageof 38
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2019
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinomaEva A Ebbing, Amber P van der Zalm, Anne Steins, et al.
Endoscopy|September 23, 2022
Wide-area transepithelial sampling with computer-assisted analysis to detect high grade dysplasia and cancer in Barrett's esophagus: a multicenter randomized studySanne N van Munster, Philippe Leclercq, Rehan Haidry, et al.
Journal of Translational Medicine|April 26, 2022
FOXO transcriptional activity is associated with response to chemoradiation in EACA Creemers, A P van der Zalm, A van de Stolpe, et al.
Endoscopy|April 13, 2013
Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter studyF G I van Vilsteren, L Alvarez Herrero, R E Pouw, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 8, 2021
Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvementM J van der Wel, E Klaver, R E Pouw, et al.
Communications Medicine|May 17, 2024
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinomaAmber P van der Zalm, Mark P G Dings, Paul Manoukian, et al.
Gastrointestinal Endoscopy|March 15, 2022
Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinomaEsther A Nieuwenhuis, Sanne N van Munster, Sybren L Meijer, et al.
Gut|June 25, 2015
Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort studyMargriet R Timmer, Pierre Martinez, Chiu T Lau, et al.
Histopathology|January 10, 2018
Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical stainingMyrtle J van der Wel, Lucas C Duits, Roos E Pouw, et al.
Cancers|March 6, 2021
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOXCharlotte I Stroes, Sandor Schokker, Remco J Molenaar, et al.
Pageof 38

Showing results (351-360 of 378) with videos related to

Sort By:
Pageof 38
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2019
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinomaEva A Ebbing, Amber P van der Zalm, Anne Steins, et al.
Endoscopy|September 23, 2022
Wide-area transepithelial sampling with computer-assisted analysis to detect high grade dysplasia and cancer in Barrett's esophagus: a multicenter randomized studySanne N van Munster, Philippe Leclercq, Rehan Haidry, et al.
Journal of Translational Medicine|April 26, 2022
FOXO transcriptional activity is associated with response to chemoradiation in EACA Creemers, A P van der Zalm, A van de Stolpe, et al.
Endoscopy|April 13, 2013
Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter studyF G I van Vilsteren, L Alvarez Herrero, R E Pouw, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 8, 2021
Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvementM J van der Wel, E Klaver, R E Pouw, et al.
Communications Medicine|May 17, 2024
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinomaAmber P van der Zalm, Mark P G Dings, Paul Manoukian, et al.
Gastrointestinal Endoscopy|March 15, 2022
Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinomaEsther A Nieuwenhuis, Sanne N van Munster, Sybren L Meijer, et al.
Gut|June 25, 2015
Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort studyMargriet R Timmer, Pierre Martinez, Chiu T Lau, et al.
Histopathology|January 10, 2018
Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical stainingMyrtle J van der Wel, Lucas C Duits, Roos E Pouw, et al.
Cancers|March 6, 2021
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOXCharlotte I Stroes, Sandor Schokker, Remco J Molenaar, et al.
Pageof 38